Dr. Salehi-Rad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Center
10833 LeConte Avenue, 43-229 CHS
Los Angeles, CA 90095Phone+1 310-825-5316Fax+1 310-825-5316
Summary
- Dr. Ramin Salehi-Rad is a pulmonologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 6 years. He specializes in critical care medicine and thoracic oncology and is experienced in respiratory failure. He has more than 20 publications and over 400 citings.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2017- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2011 - 2014
David Geffen School of Medicine at UCLAClass of 2011
Certifications & Licensure
CA State Medical License 2012 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 142 citationsPhase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration.Jay M. Lee, Mi-Heon Lee, Edward B. Garon, Jonathan W. Goldman, Ramin Salehi-Rad
Clinical Cancer Research. 2017-08-15 - 50 citationsInhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung CancerRui Li, Ramin Salehi-Rad, William P. Crosson, Milica Momcilovic, Raymond J. Lim
Cancer Research. 2021-04-14 - 5 citationsCXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer.Raymond J Lim, Ramin Salehi-Rad, Linh M Tran, Michael S Oh, Camelia Dumitras
Cell Reports. Medicine. 2024-04-16
Press Mentions
Young Investigators Awarded $200k to Study Innovative New Ways to Engage the Body’s Immune System to Fight Lung CancerJanuary 17th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
